Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000950170-25-102093
Filing Date
2025-08-04
Accepted
2025-08-04 16:46:22
Documents
2
Period of Report
2025-07-31

Document Format Files

Seq Description Document Type Size
1 3 ownership.html 3  
1 3 ownership.xml 3 1503
2 EX-24 rxst-ex24.htm EX-24 11372
  Complete submission text file 0000950170-25-102093.txt   14460
Mailing Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656
Business Address 100 COLUMBIA STREET SUITE 120 ALISO VIEJO CA 92656 949-521-7822
RxSight, Inc. (Issuer) CIK: 0001111485 (see all company filings)

EIN.: 943268801 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3851 Ophthalmic Goods
(CF Office: 08 Industrial Applications and Services)

Mailing Address C/O KESTRA MEDICAL TECHNOLOGIES, LTD. 3933 LAKE WASHINGTON BLVD NE, SUITE 200 KIRKLAND WA 98033
Business Address
COHEN RAYMOND W (Reporting) CIK: 0001258288 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40690 | Film No.: 251181069